GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CAPR
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Capricor Therapeutics stock price on Wednesday moving between $5.44 and $6.05
(Updated on Apr 17, 2024)

Sell candidate since Apr 15, 2024 Loss -5.29% PDF

The Capricor Therapeutics stock price fell by -6.41% on the last day (Wednesday, 17th Apr 2024) from $5.93 to $5.55. During the last trading day the stock fluctuated 11.21% from a day low at $5.44 to a day high of $6.05. The price has fallen in 6 of the last 10 days and is down by -18.38% for this period. Volume has increased on the last day by 202 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 478 thousand shares were bought and sold for approximately $2.65 million.

Given the current short-term trend, the stock is expected to rise 82.70% during the next 3 months and, with a 90% probability hold a price between $10.14 and $14.21 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CAPR Signals & Forecast

There are few to no technical positive signals at the moment. The Capricor Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $6.10 and $6.08. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 01, 2024, and so far it has fallen -21.78%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Capricor Therapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $5.19 and $4.57. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Capricor Therapeutics finds support just below today's level at $5.19. If this is broken, then the next support from accumulated volume will be at $4.57 and $4.34.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.610 between high and low, or 11.21%. For the last week, the stock has had daily average volatility of 8.16%.

Capricor Therapeutics is oversold on RSI14 (21). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CAPR) For The Upcoming Trading Day Of Thursday 18th

For the upcoming trading day on Thursday, 18th we expect Capricor Therapeutics to open at $5.68, and during the day (based on 14 day Average True Range), to move between $5.10 and $6.00, which gives a possible trading interval of +/-$0.448 (+/-8.06%) up or down from last closing price. If Capricor Therapeutics takes out the full calculated possible swing range there will be an estimated 16.13% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $5.89 (6.13%) than the support at $5.19 (6.58%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Capricor Therapeutics stock A Buy?

The Capricor Therapeutics stock holds several negative signals and despite the positive trend, we believe Capricor Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.263 Sell Candidate Unchanged

Predicted Opening Price for Capricor Therapeutics of Thursday, April 18, 2024

Fair opening price April 18, 2024 Current price
$5.68 ( 2.34%) $5.55

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CAPR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 6.29 13.33 %
R2 6.06 9.13 %
R1 5.91 6.54 %
Current price: 5.55
Support S1 5.45 -1.86 %
S2 5.30 -4.45 %
S3 5.07 -8.65 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 6.79 22.34 %
R2 6.38 14.95 %
R1 5.89 6.13 %
Current price 5.55
Support S1 5.19 -6.58%
S2 4.57 -17.75%
S3 4.34 -21.80%

FAQ

What is the symbol for Capricor Therapeutics Stock and on which exchange is it traded?
The symbol for Capricor Therapeutics is CAPR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Capricor Therapeutics Stock?
The Capricor Therapeutics stock holds several negative signals and despite the positive trend, we believe Capricor Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Capricor Therapeutics Stock?
Capricor Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Capricor Therapeutics Stock.

What's the current price of Capricor Therapeutics Stock?
As of the end of day on the 2024-04-17, the price of an Capricor Therapeutics (CAPR) share was $5.55.

What is the 52-week high and low for Capricor Therapeutics Stock?
The 52-week high for Capricor Therapeutics Stock is $8.22 and the 52-week low is $2.68.

What is the market capitalization of Capricor Therapeutics Stock?
As of the 2024-04-17, the market capitalization of Capricor Therapeutics is 174.842M.

When is the next earnings date for Capricor Therapeutics?
The upcoming earnings date for Capricor Therapeutics is May 09, 2024.
Click to get the best stock tips daily for free!

About Capricor Therapeutics

Capricor Therapeutics Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Ph... CAPR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT